DataHow has successfully closed a Series A financing round. In so doing, the Zurich-based company, which was founded in 2017, has secured fresh capital to enhance its digital platform for the development and manufacturing of bioprocesses by the name of DataHowLab, which it ultimately hopes to launch on the market. No details were disclosed on the value of the transaction.
According to a press release issued by the spin off from the Swiss Federal Institute of Technology in Zurich, the financing round was led by the venture capital firm Momenta, which is based in Meggen in the canton of Lucerne in Switzerland and focuses on industrial processes. Moreover, other participants included Rockwell Automation, an automation company based in the US State of Wisconsin, and Zürcher Kantonalbank, the cantonal bank of Zurich.
“The past several years have reinforced the value of flexible and rapid scale in bioprocess manufacturing, quickly bringing new medicines and compounds to improve the environment, and people’s quality of life”, as Ken Forster, Executive Director of Momenta, explains in the press release. “DataHow is a pioneer in applying AI models to accelerate the scale-up of bioprocess manufacturing”.
According to Dr. Alessandro Butté, co-founder and CEO of DataHow, the company was looking for, and has now found, investment partners that grasp the impacts of digitalization on manufacturing and that are firmly anchored in the market, ecosystem, technology and culture. “We have a deep understanding of research and development but need partners now to help us scale up our market and solutions towards manufacturing and regulated production environments”, he explains. ce/mm
Related news
Meet with an expansion expert
Our services are free of charge and include:
- Introduction to key contacts in industry, academia, and government
- Advice on regulatory framework, taxes, labor, market, and setting up a company
- Custom-made fact-finding visits, including office and co-working space